Deepa H. Chand
Novartis (Switzerland)(CH)Illinois College(US)Children's Hospital of Illinois(US)
Publications by Year
Research Areas
Dialysis and Renal Disease Management, Central Venous Catheters and Hemodialysis, Neurogenetic and Muscular Disorders Research, Acute Kidney Injury Research, Vascular Procedures and Complications
Most-Cited Works
- → Fluid Overload and Mortality in Children Receiving Continuous Renal Replacement Therapy: The Prospective Pediatric Continuous Renal Replacement Therapy Registry(2009)685 cited
- → Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial(2021)456 cited
- → Demographic Characteristics of Pediatric Continuous Renal Replacement Therapy(2007)297 cited
- → Hepatotoxicity following administration of onasemnogene abeparvovec (AVXS-101) for the treatment of spinal muscular atrophy(2020)286 cited
- → Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial(2021)241 cited
- → Thrombotic Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series